BIOEN.E — Biotrend Cevre ve Enerji Yatirimlari AS Cashflow Statement

0.000.00%

Last trade - 00:00

UtilitiesSpeculativeSmall CapNeutral

Market Cap
TRY9.52bn
Enterprise Value
TRY12.36bn
Revenue
TRY1.23bn

Annual cashflow statement for Biotrend Cevre ve Enerji Yatirimlari AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-1.46	2.75	49.9	1.24	311
Depreciation
Non-Cash Items	11	9.61	47.6	3.91	-179
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-13.1	32.1	-67	-364	-187
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	8.29	58.2	53	-326	48.2
Capital Expenditures	-41.6	-106	-287	-441	-897
Purchase of Fixed Assets
Other Investing Cash Flow Items	-4.49	3.62	-43.7	1.1	-17.8
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Other Investing Cash Flow
Cash from Investing Activities	-46.1	-102	-331	-440	-915
Financing Cash Flow Items	-9.93	-9.49	-10.9	-23.7	-66.8
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	46.4	52.9	361	835	724
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	8.57	8.76	83.5	69.1	-143